26 companies

Genomed Spólka Akcyjna

Market Cap: zł37.8m

Provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland.

GEN

zł28.60

7D

4.4%

1Y

3.6%

Captor Therapeutics Spolka Akcyjna

Market Cap: zł222.8m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

CTX

zł40.40

7D

10.4%

1Y

-46.6%

Poltreg

Market Cap: zł121.2m

A biotechnology company, researches and develops therapies for autoimmune diseases.

PTG

zł26.00

7D

0%

1Y

-52.7%

Read-Gene

Market Cap: zł72.9m

Engages in the detection, prevention, and treatment of various types of cancer.

RDG

zł6.20

7D

1.3%

1Y

12.3%

Molecure

Market Cap: zł150.1m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.

MOC

zł7.37

7D

-1.6%

1Y

-42.0%

Selvita

Market Cap: zł704.9m

Operates as a contract research organization worldwide.

SLV

zł38.20

7D

0.8%

1Y

-33.6%

Biogened

Market Cap: zł59.0m

Develops, produces, and distributes pharmaceutical products in Poland.

BGD

zł24.00

7D

-3.2%

1Y

4.3%

Vinci Gen

Market Cap: zł2.9m

Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.

VGN

zł0.24

7D

-10.4%

1Y

-50.4%

Stem Cells Spin

Market Cap: zł18.0m

Operates as a biotechnology company in Poland.

SCS

zł0.41

7D

-2.9%

1Y

94.3%

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

HEN

zł2.32

7D

0%

1Y

-22.4%

genXone

Market Cap: zł18.2m

Operates in the biotechnology industry in Poland and internationally.

GX1

zł5.56

7D

-5.4%

1Y

-8.3%

BIOTON

Market Cap: zł384.7m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

BIO

zł4.43

7D

-1.6%

1Y

30.3%

Labocanna

Market Cap: zł5.8m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.27

7D

-5.9%

1Y

-30.2%

Green Zebras Spolka Akcyjna

Market Cap: zł12.0m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

GRZ

zł9.10

7D

4.0%

1Y

-39.5%

NanoGroup

Market Cap: zł86.1m

Operates as a biotechnology company in Poland.

NNG

zł2.74

7D

-2.8%

1Y

-32.8%

Bioceltix

Market Cap: zł498.4m

Engages in the development of stem cell-based biopharmaceuticals for veterinary use.

BCX

zł101.40

7D

-3.2%

1Y

49.1%

Cannabis Poland

Market Cap: zł14.7m

Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland.

CBD

zł0.29

7D

0.3%

1Y

-45.3%

Urteste

Market Cap: zł65.8m

Engages in the research and development of diagnostic tests for cancers.

URT

zł44.60

7D

-1.8%

1Y

-49.3%

Celon Pharma

Market Cap: zł1.2b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.

CLN

zł21.80

7D

-0.5%

1Y

-20.6%

Genomtec

Market Cap: zł104.5m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

GMT

zł6.93

7D

0.1%

1Y

-7.2%

Medicofarma Biotech

Market Cap: zł53.6m

A biotechnology company, provides medicines, medicinal products, and biotechnology products.

MDB

zł0.77

7D

-5.9%

1Y

45.6%

Mabion

Market Cap: zł139.6m

A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.

MAB

zł8.60

7D

-3.6%

1Y

-47.5%

Ryvu Therapeutics

Market Cap: zł513.0m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł27.80

7D

1.5%

1Y

-46.9%

Pure Biologics

Market Cap: zł25.7m

A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.

PUR

zł6.29

7D

-0.7%

1Y

-70.0%

Synthaverse

Market Cap: zł317.1m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.

SVE

zł4.38

7D

-0.2%

1Y

0.2%

Bioerg Spólka Akcyjna

Market Cap: zł13.8m

Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland.

BER

zł0.14

7D

0%

1Y

-17.6%